Fibclot

Human Fibrinogen (Fibclot) is a clotting factor used to manage bleeding disorders. This intravenous medication supports blood coagulation, crucial for surgical and emergency care.

Human Fibrinogen, also known as Fibclot, is primarily used to control bleeding in individuals with congenital fibrinogen deficiency. It is often administered intravenously to promote blood clotting during surgical procedures or in emergency situations where rapid hemostasis is required. This medication is essential for patients who experience excessive bleeding due to low fibrinogen levels.

When administered, Human Fibrinogen works to enhance the body's natural clotting process. Common effects include improved coagulation at the site of injury or surgical incision. Patients may experience localized reactions at the injection site, such as mild discomfort or redness.

Human Fibrinogen should be handled with care, ensuring proper storage and administration by healthcare professionals. Patients with a history of allergic reactions to blood products should use this medication with caution. Always follow the guidance of a healthcare provider when using Fibclot.

Human Fibrinogen may interact with other medications that affect blood clotting, such as anticoagulants or antiplatelet drugs. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should also be discussed with a healthcare professional.